The biotech space has witnessed radical transformations in the last 15 years, both globally and in India. Worth $50 Bn in 2018, the Indian biotech economy currently comprises of more than 600 core biotechnology companies and more than 2,600 biotech startups, accounting for a 3% share in the global biotechnology industry. To further unleash the potential of Indian biotech, Biotechnology Industry Research Assistance Council (BIRAC), in partnership with Indian Angel Network (IAN), has announced the launch of BioAngels Network “BioAngels” (BiAN). IAN comprises close to 500 members across the world, including entrepreneurs and CEOs. With investors from 11 countries, IAN’s presence spans seven locations, including cities in India and the UK.
The network has funded startups across 17 sectors Bold-Max Maxtreme buy in USA legally in India and seven other countries so far, with the portfolio including WebEngage, Druva, Box8, Sapience Analytics, WOW Momos, Consure among others.
The IAN recently launched an INR 450 Cr fund, where entrepreneurs can raise between INR 25 Lakh and INR 50 Cr and also gain support from its roster of mentors, entrepreneurs and angels. BIRAC has infused INR 978 Cr in this space along with committing INR 937 Cr to the industry in the last seven years.
Since its launch, 750+ biotech startups have been supported by BIRAC and together achieved a valuation of more than INR 3,500 Cr. Around 33 such companies have achieved a valuation of INR 365.4 Cr in the last three years alone.
BIRAC is a not-for-profit public sector enterprise, set up by the department of biotechnology (DBT) under the ministry of science and technology, as an interface agency to strengthen and empower emerging biotech enterprises to undertake strategic research and innovation. The collaboration of BIRAC and IAN aims to create the single largest national platform for biotech angel investing.
BioAngels Network Looks To Fuel Biotech Innovation
BiAN is created as an open architecture platform to build an ecosystem conducive to the growth and proliferation of biotech startups.
“To achieve this, BiAN is committed to supporting biotech innovators who are developing affordable and accessible products that solve major pain points of society today,” COO of Indian Angel Network, Digvijay Singh, told Inc42.
The IAN and BIRAC collaboration should allow innovators to gain a stronger footing in the high-risk, high-cost biotech sector. The collaboration will also facilitate the growth of Indian biotech enterprises and startups, opening up much higher levels of funding, talent, and market access. “It seeks to build an ecosystem of domain experts to help investors understand the innovation in biotech and its critical need; a network of business mentors; and network of R&D facilities, corporates, etc. to help companies pilot, validate, and grow,” Singh added.
The BioAngels Network will also be working on creating overseas partnerships for validation, patenting, next rounds, among others. An investor base of 50 angel investors, 20 family offices or strategic investors, and ten corporates will be created over the next three years. It also plans to invest INR 1 Cr to support 100 ventures; making 25 investments worth INR 3 Cr – INR 5 Cr, and 20 investments ranging from INR 7 Cr to INR10 Cr in the same time period.
In addition to being one of the 12 largest biotech economies in the world, India is also the third most sought-after biotech destination in the Asia Pacific Region.
The BioAngels Network initiative will be driven by a robust operational focus, frameworks, processes, and governance, and powered by an inclusive group of ecosystem stakeholders. These include HNIs, angel investors, family offices, strategic investors, corporates, and VCs. The platform will facilitate the expansion of BIRAC’s empowering policies, mentoring, and market access to biotech innovators across India and overseas by leveraging the geographical reach and industry linkages of IAN.
“Biotech startups are focused on creating a transformational impact in India before they disrupt global markets. They hold the key to unlocking a healthier, tech-driven future for India along with the unparalleled potential of digital healthcare,” said Manish Diwan, head of strategic partnership and entrepreneurship development, BIRAC, in a statement.
He added that BiAN creates a unique opportunity to bring in equity investments for startups that have hitherto been neglected largely by the major investors in India, especially in the early-stage where capital is key for product development and R&D.
